Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Evaluation of Ebola Virus Inhibitors for Drug Repurposing.

Madrid PB, Panchal RG, Warren TK, Shurtleff AC, Endsley AN, Green CE, Kolokoltsov A, Davey R, Manger ID, Gilfillan L, Bavari S, Tanga MJ.

ACS Infect Dis. 2015 Jul 10;1(7):317-26. doi: 10.1021/acsinfecdis.5b00030. Epub 2015 May 11.

PMID:
27622822
2.

A systematic screen of FDA-approved drugs for inhibitors of biological threat agents.

Madrid PB, Chopra S, Manger ID, Gilfillan L, Keepers TR, Shurtleff AC, Green CE, Iyer LV, Dilks HH, Davey RA, Kolokoltsov AA, Carrion R Jr, Patterson JL, Bavari S, Panchal RG, Warren TK, Wells JB, Moos WH, Burke RL, Tanga MJ.

PLoS One. 2013;8(4):e60579. doi: 10.1371/journal.pone.0060579. Epub 2013 Apr 5.

3.

Alphaviruses: population genetics and determinants of emergence.

Weaver SC, Winegar R, Manger ID, Forrester NL.

Antiviral Res. 2012 Jun;94(3):242-57. doi: 10.1016/j.antiviral.2012.04.002. Epub 2012 Apr 19. Review.

4.

Microfluidic device for single-cell analysis.

Wheeler AR, Throndset WR, Whelan RJ, Leach AM, Zare RN, Liao YH, Farrell K, Manger ID, Daridon A.

Anal Chem. 2003 Jul 15;75(14):3581-6.

PMID:
14570213
5.

Targeted disruption of an essential RNA-binding protein perturbs cell division in Trypanosoma brucei.

Manger ID, Boothroyd JC.

Mol Biochem Parasitol. 2001 Sep 3;116(2):239-45. No abstract available.

PMID:
11522358
6.

Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells.

Blader IJ, Manger ID, Boothroyd JC.

J Biol Chem. 2001 Jun 29;276(26):24223-31. Epub 2001 Apr 9.

7.

How the host 'sees' pathogens: global gene expression responses to infection.

Manger ID, Relman DA.

Curr Opin Immunol. 2000 Apr;12(2):215-8. Review.

PMID:
10712949
8.
10.

Expressed sequence tag analysis of the bradyzoite stage of Toxoplasma gondii: identification of developmentally regulated genes.

Manger ID, Hehl A, Parmley S, Sibley LD, Marra M, Hillier L, Waterston R, Boothroyd JC.

Infect Immun. 1998 Apr;66(4):1632-7.

11.

The surface of Toxoplasma: more and less.

Boothroyd JC, Hehl A, Knoll LJ, Manger ID.

Int J Parasitol. 1998 Jan;28(1):3-9. Review.

PMID:
9504330
12.

Gene discovery by EST sequencing in Toxoplasma gondii reveals sequences restricted to the Apicomplexa.

Ajioka JW, Boothroyd JC, Brunk BP, Hehl A, Hillier L, Manger ID, Marra M, Overton GC, Roos DS, Wan KL, Waterston R, Sibley LD.

Genome Res. 1998 Jan;8(1):18-28.

13.
14.

Genetic and biochemical analysis of development in Toxoplasma gondii.

Boothroyd JC, Black M, Bonnefoy S, Hehl A, Knoll LJ, Manger ID, Ortega-Barria E, Tomavo S.

Philos Trans R Soc Lond B Biol Sci. 1997 Sep 29;352(1359):1347-54.

15.

Analysis of carbohydrate-protein interactions with synthetic N-linked neoglycoconjugate probes.

Wong SY, Manger ID, Guile GR, Rademacher TW, Dwek RA.

Biochem J. 1993 Dec 15;296 ( Pt 3):817-25.

16.

Enzymatic characterization of beta-D-galactoside alpha 2,3-trans-sialidase from Trypanosoma cruzi.

Scudder P, Doom JP, Chuenkova M, Manger ID, Pereira ME.

J Biol Chem. 1993 May 5;268(13):9886-91.

18.

1-N-glycyl beta-oligosaccharide derivatives as stable intermediates for the formation of glycoconjugate probes.

Manger ID, Rademacher TW, Dwek RA.

Biochemistry. 1992 Nov 10;31(44):10724-32. Erratum in: Biochemistry 1993 Apr 13;32(14):3829.

PMID:
1420188
19.

Viral glycoprotein heterogeneity-enhancement of functional diversity.

Schulze IT, Manger ID.

Glycoconj J. 1992 Apr;9(2):63-6. Review.

PMID:
1344709

Supplemental Content

Loading ...
Support Center